V
VKTX
Viking Therapeutics Inc
32.74
+0.55+1.71%After Hours: 32.75 +0.01 +0.03%19:55 05/29 EDT
OPEN/PREV CLOSE32.25/32.19
TODAY RANGE31.81-33.16
VOL1.75M
MARKET CAP3.80B
52 WEEK RANGE22.96-43.15
AVG VOL (3M)2.28M
% TURNOVER1.51%
TURNOVER--
P/E (TTM)-7.8971
% RANGE4.19%
EPS(TTM)-4.1458
P/E(FORWARD)-6.7366
P/B7.56
BVPS4.331
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.70B
SHARES OUTSTANDING116.11M
NEXT EARNINGS07/21-07/27
FREE FLOAT112.87M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Viking Therapeutics assumed with a Buy at Truist
Dow Jones·05/21 20:32
Corbus Pharmaceuticals Holdings Inc. Stock Rises 18.3%, Outperforms Peers
PR Newswire·05/21 11:05
Viking Therapeutics to Participate at Upcoming Investor Conferences
Dow Jones·05/20 20:35
Corbus Pharmaceuticals Holdings Inc. Stock Rallies 6.3%, Outperforms Peers
Dow Jones·05/19 20:33
Corbus Pharmaceuticals Holdings Inc. Stock Slips 8.0%, Underperforms Peers
Dow Jones·05/18 20:33
Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.